Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12363) 12363
Publication (1607) 1607
Newsletter (157) 157
Book Review (153) 153
Newspaper Article (57) 57
Book Chapter (44) 44
Magazine Article (35) 35
Book / eBook (9) 9
Conference Proceeding (9) 9
Data Set (7) 7
Trade Publication Article (5) 5
Transcript (4) 4
Dissertation (2) 2
Report (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (10934) 10934
hiv infections - drug therapy (7013) 7013
drug therapy, combination (6741) 6741
male (5878) 5878
female (5640) 5640
adult (5189) 5189
index medicus (5031) 5031
infectious diseases (4981) 4981
hiv (4049) 4049
anti-hiv agents - therapeutic use (3966) 3966
middle aged (3398) 3398
immunology (3052) 3052
antiretroviral therapy (2624) 2624
viral load (2514) 2514
treatment outcome (2407) 2407
hiv infections - virology (2402) 2402
virology (2298) 2298
cd4 lymphocyte count (2143) 2143
pharmacology & pharmacy (2075) 2075
drug therapy (2010) 2010
hiv infection (2007) 2007
aids (1928) 1928
combination therapy (1914) 1914
anti-hiv agents - administration & dosage (1767) 1767
antiviral agents (1736) 1736
hiv-1 - drug effects (1672) 1672
human-immunodeficiency-virus (1619) 1619
reverse transcriptase inhibitors - therapeutic use (1567) 1567
hiv infections - complications (1448) 1448
hiv infections - immunology (1446) 1446
health aspects (1435) 1435
antiretroviral therapy, highly active (1368) 1368
human immunodeficiency virus--hiv (1338) 1338
combination (1325) 1325
infection (1311) 1311
hiv-1 (1306) 1306
anti-hiv agents - adverse effects (1298) 1298
protease inhibitors (1276) 1276
therapy (1262) 1262
highly active antiretroviral therapy (1258) 1258
research (1245) 1245
hiv protease inhibitors - therapeutic use (1211) 1211
microbiology (1198) 1198
drug combinations (1168) 1168
rna, viral - blood (1139) 1139
care and treatment (1127) 1127
adolescent (1109) 1109
hiv-1 - genetics (1096) 1096
risk factors (1083) 1083
antiviral agents - therapeutic use (1066) 1066
active antiretroviral therapy (1022) 1022
zidovudine (1017) 1017
combination antiretroviral therapy (987) 987
aged (961) 961
medicine, general & internal (950) 950
antiretroviral drugs (937) 937
drug administration schedule (934) 934
cohort studies (924) 924
dosage and administration (851) 851
aids/hiv (845) 845
lamivudine (841) 841
tenofovir (840) 840
young adult (837) 837
prospective studies (823) 823
retrospective studies (820) 820
mortality (801) 801
analysis (778) 778
pharmacokinetics (770) 770
lamivudine - therapeutic use (768) 768
drug interactions (766) 766
zidovudine - therapeutic use (764) 764
child (757) 757
anti-hiv agents - pharmacology (748) 748
human immunodeficiency virus (733) 733
ritonavir - therapeutic use (723) 723
article (718) 718
ritonavir (712) 712
efficacy (711) 711
infections (704) 704
hiv patients (703) 703
virus diseases (691) 691
anti-retroviral agents - therapeutic use (675) 675
time factors (675) 675
hiv-infected patients (666) 666
hiv infections - epidemiology (664) 664
genotype (657) 657
acquired immunodeficiency syndrome - drug therapy (649) 649
animals (644) 644
adenine - analogs & derivatives (628) 628
drug resistance (623) 623
pregnancy (621) 621
immunodeficiency-virus type-1 (614) 614
reverse transcriptase inhibitors - administration & dosage (614) 614
mutation (606) 606
efavirenz (601) 601
safety (594) 594
hiv-1 - physiology (593) 593
antiretrovirals (592) 592
drug resistance, viral (583) 583
infected patients (578) 578
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (8) 8
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Missing (1) 1
Online Resources - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12078) 12078
Spanish (192) 192
French (161) 161
German (136) 136
Japanese (23) 23
Italian (19) 19
Dutch (13) 13
Portuguese (11) 11
Chinese (8) 8
Russian (6) 6
Czech (5) 5
Danish (5) 5
Polish (4) 4
Croatian (2) 2
Turkish (2) 2
Hebrew (1) 1
Lithuanian (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Integration of Antiretroviral Therapy with Tuberculosis Treatment
by Abdool Karim, Quarraisha and Abdool Karim, Salim S and Naidoo, Kogieleum and Naidoo, Anushka and Grobler, Anneke and Padayatchi, Nesri and Baxter, Cheryl and Gray, Andrew L and Gengiah, Tanuja and Gengiah, Santhanalakshmi and Jithoo, Niraksha and Nair, Gonasagrie and El-Sadr, Wafaa M and Friedland, Gerald
The New England Journal of Medicine, ISSN 0028-4793, 10/2011, Volume 365, Issue 16, pp. 1492 - 1501
In this study from South Africa, earlier initiation of antiretroviral therapy in patients with newly diagnosed HIV infection and TB was associated with higher... 
SOUTH-AFRICA | MEDICINE, GENERAL & INTERNAL | HIV | INITIATION | EFAVIRENZ | DRUGS | Drug Administration Schedule | Humans | AIDS-Related Opportunistic Infections - drug therapy | Kaplan-Meier Estimate | Tuberculosis - complications | Male | CD4 Lymphocyte Count | Viral Load | Disease-Free Survival | Anti-Retroviral Agents - administration & dosage | Tuberculosis - drug therapy | HIV Infections - complications | Adult | Female | HIV Infections - drug therapy | HIV Infections - mortality | Antitubercular Agents - therapeutic use | Antiviral agents | Usage | Care and treatment | Patient outcomes | Comorbid patients | Tuberculosis | Antitubercular agents | Dosage and administration | Drug therapy, Combination | Diagnosis | Drug therapy | Health aspects | HIV infection | Bacilli | Cell survival | Immune reconstitution | Lymphocytes T | Inflammation | Patients | Immunosuppressive agents | Antiretroviral therapy | CD4 antigen | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Sputum | Death
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Prevention of HIV-1 Infection with Early Antiretroviral Therapy
by Cohen, Myron S and Chen, Ying Q and McCauley, Marybeth and Gamble, Theresa and Hosseinipour, Mina C and Kumarasamy, Nagalingeswaran and Hakim, James G and Kumwenda, Johnstone and Grinsztejn, Beatriz and Pilotto, Jose H.S and Godbole, Sheela V and Mehendale, Sanjay and Chariyalertsak, Suwat and Santos, Breno R and Mayer, Kenneth H and Hoffman, Irving F and Eshleman, Susan H and Piwowar-Manning, Estelle and Wang, Lei and Makhema, Joseph and Mills, Lisa A and de Bruyn, Guy and Sanne, Ian and Eron, Joseph and Gallant, Joel and Havlir, Diane and Swindells, Susan and Ribaudo, Heather and Elharrar, Vanessa and Burns, David and Taha, Taha E and Nielsen-Saines, Karin and Celentano, David and Essex, Max and Fleming, Thomas R and HPTN 052 Study Team
The New England Journal of Medicine, ISSN 0028-4793, 08/2011, Volume 365, Issue 6, pp. 493 - 505
In this large, international study of HIV-1–serodiscordant couples, the receipt of antiretroviral therapy by the infected partner decreased transmission to the... 
MORTALITY | MEDICINE, GENERAL & INTERNAL | TRANSMISSION | COUNTRIES | INITIATION | MALAWI | IMMUNODEFICIENCY-VIRUS TYPE-1 | RETHINKING | HIV-1-INFECTED PATIENTS | COHORT | UGANDA | HIV-1 | HIV Infections - prevention & control | Anti-Retroviral Agents - therapeutic use | HIV Seropositivity | Humans | Anti-Retroviral Agents - adverse effects | Kaplan-Meier Estimate | Proportional Hazards Models | Male | Spouses | Treatment Outcome | Disease Progression | Disease Transmission, Infectious - prevention & control | Young Adult | Adolescent | Adult | Female | HIV Infections - drug therapy | HIV Infections - transmission | Sexual Partners | Drug Therapy, Combination | Antiviral agents | Usage | Patient outcomes | Management | Drug therapy | Health aspects | HIV infection | Public health | Fees & charges | Antiretroviral drugs | Couples | Enrollments | Laboratories | Hypersensitivity | Sexual transmission | Infections | Grants | Antiretroviral therapy | CD4 antigen | Disease prevention | Studies | Infectious diseases | Disease transmission | Tuberculosis | Human immunodeficiency virus--HIV | Counseling | Population
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Early Antiretroviral Therapy and Mortality among HIV-Infected Infants
by Violari, Avy and Cotton, Mark F and Gibb, Diana M and Babiker, Abdel G and Steyn, Jan and Madhi, Shabir A and Jean-Philippe, Patrick and McIntyre, James A and CHER Study Team
The New England Journal of Medicine, ISSN 0028-4793, 11/2008, Volume 359, Issue 21, pp. 2233 - 2244
The timing of initiation of antiretroviral therapy in HIV-infected infants has been debated, in part because of the potential long-term toxicity of the... 
SURVIVAL | TRIAL | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | ZIDOVUDINE | HIV-1-INFECTED CHILDREN | COHORT | REGIMENS | DISEASE PROGRESSION | HIV-1 | Lamivudine - administration & dosage | Follow-Up Studies | Humans | Infant | Male | Zidovudine - administration & dosage | Anti-HIV Agents - administration & dosage | Lamivudine - adverse effects | Ritonavir - adverse effects | Treatment Failure | Female | HIV Infections - mortality | Drug Therapy, Combination | Drug Administration Schedule | Ritonavir - administration & dosage | Zidovudine - adverse effects | Anti-HIV Agents - adverse effects | Lopinavir | Pyrimidinones - adverse effects | CD4 Lymphocyte Count | Infectious Disease Transmission, Vertical | Disease Progression | HIV Infections - drug therapy | Pyrimidinones - administration & dosage | Antiviral agents | Control | Patient outcomes | Dosage and administration | HIV infection in children | Infants | Diagnosis | Antiretroviral drugs | Hospitals | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Mortality | Infections | Drug therapy | Age | Children & youth | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention
by Fowler, Mary G and Qin, Min and Fiscus, Susan A and Currier, Judith S and Flynn, Patricia M and Chipato, Tsungai and McIntyre, James and Gnanashanmugam, Devasena and Siberry, George K and Coletti, Anne S and Taha, Taha E and Klingman, Karin L and Martinson, Francis E and Owor, Maxensia and Violari, Avy and Moodley, Dhayendre and Theron, Gerhard B and Bhosale, Ramesh and Bobat, Raziya and Chi, Benjamin H and Strehlau, Renate and Mlay, Pendo and Loftis, Amy J and Browning, Renee and Fenton, Terence and Purdue, Lynette and Basar, Michael and Shapiro, David E and Mofenson, Lynne M and IMPAACT 1077BF 1077FF PROMISE Stud and IMPAACT 1077BF/1077FF PROMISE Study Team
The New England Journal of Medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 18, pp. 1726 - 1737
In this randomized, controlled trial in Africa and India, combination antiretroviral therapy was more effective than standard therapy in preventing... 
PRETERM DELIVERY | CHILD-MORTALITY | MEDICINE, GENERAL & INTERNAL | TENOFOVIR DISOPROXIL FUMARATE | INFECTED WOMEN | PROGESTERONE LEVELS | ADVERSE BIRTH OUTCOMES | LOPINAVIR/RITONAVIR | LOPINAVIR EXPOSURE | PROTEASE | PREGNANCY | HIV Infections - prevention & control | Infant Mortality | Humans | African Americans | Perinatal Care | Infant | Young Adult | Adult | Female | HIV Infections - transmission | Drug Therapy, Combination | Infant, Newborn | Infant, Low Birth Weight | Anti-Retroviral Agents - therapeutic use | Tenofovir - therapeutic use | Zidovudine - adverse effects | Anti-Retroviral Agents - adverse effects | CD4 Lymphocyte Count | Gestational Age | Pregnancy | Infant, Premature | Zidovudine - therapeutic use | HIV Infections - ethnology | Nevirapine - administration & dosage | Infectious Disease Transmission, Vertical - prevention & control | Pregnancy Outcome | Prevention | Highly active antiretroviral therapy | Complications and side effects | Care and treatment | Nevirapine | Pregnant women | HIV patients | Dosage and administration | Research | HIV (Viruses) | Zidovudine | Health aspects | Emtricitabine | Neonates | Antiretroviral drugs | Breastfeeding & lactation | Ritonavir | Lopinavir | Lamivudine | Infants | Gestation | Antiretroviral therapy | Postpartum | CD4 antigen | Disease prevention | Tenofovir | Cost-benefit analysis | Disease transmission | Maternal & child health | Human immunodeficiency virus--HIV | Birth weight | Drug therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Timing of Initiation of Antiretroviral Therapy in Human Immunodeficiency Virus (HIV)—Associated Tuberculous Meningitis
by M. Estee Török and Nguyen Thi Bich Yen and Tran Thi Hong Chau and Nguyen Thi Hoang Mai and Nguyen Hoan Phu and Pham Phuong Mai and Nguyen Thi Dung and Nguyen Van Vinh Chau and Nguyen Duc Bang and Nguyen Anh Tien and N. H. Minh and Nguyen Quang Hien and Phan Vuong Khac Thai and Doan The Dong and Do Thi Tuong Anh and Nguyen Thi Cam Thoa and Nguyen Ngoc Hai and Nguyen Ngoc Lan and Nguyen Thi Ngoc Lan and Hoang Thi Quy and Nguyen Huy Dung and Tran Tinh Hien and Nguyen Tran Chinh and Cameron Paul Simmons and Menno de Jong and Marcel Wolbers and Jeremy James Farrar
Clinical Infectious Diseases, ISSN 1058-4838, 6/2011, Volume 52, Issue 11, pp. 1374 - 1383
Background. The optimal time to initiate antiretroviral therapy (ART) in human immunodeficiency virus (HIV)—associated tuberculous meningitis is unknown.... 
Statistical median | HIV/AIDS | Antiretrovirals | Art therapy | Meningeal tuberculosis | HIV | Mortality | Random allocation | AIDS | Arts | HIV 1 | MORTALITY | SURVIVAL | THAILAND | INFECTIOUS DISEASES | HIV-INFECTION | ERA | ADOLESCENTS | CLINICAL-TRIALS | ADULTS | RISK | MICROBIOLOGY | IMMUNOLOGY | Lamivudine - administration & dosage | Humans | Antiretroviral Therapy, Highly Active - adverse effects | Male | Zidovudine - administration & dosage | Anti-HIV Agents - administration & dosage | Time Factors | Adult | Anti-Inflammatory Agents - administration & dosage | Female | HIV Infections - mortality | Antiretroviral Therapy, Highly Active - methods | Tuberculosis, Meningeal - mortality | Placebos - administration & dosage | Dexamethasone - administration & dosage | Tuberculosis, Meningeal - drug therapy | Benzoxazines - administration & dosage | Double-Blind Method | Trimethoprim, Sulfamethoxazole Drug Combination - administration & dosage | Anti-HIV Agents - adverse effects | Treatment Outcome | Tuberculosis, Meningeal - complications | HIV Infections - complications | Antitubercular Agents - administration & dosage | HIV Infections - drug therapy | Antiviral agents | Care and treatment | Patient outcomes | Dosage and administration | Drug therapy | Health aspects | HIV infection | Comorbid patients | Tuberculous meningitis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Advances in antiretroviral therapy
by Arribas, Jose R and Eron, Joseph
Current Opinion in HIV and AIDS, ISSN 1746-630X, 07/2013, Volume 8, Issue 4, pp. 341 - 349
PURPOSE OF REVIEWTo review recent data about advances in ART. RECENT FINDINGSIn the last 2 years, clinical trials have demonstrated the safety and efficacy of... 
darunavir/ritonavir | lopinavir/ritonavir | generic antiretrovirals | maraviroc | nevirapine | atazanavir | elvitegravir | raltegravir | nucleoside-sparing | dolutegravir | cobicistat | rilpivirine | INFECTIOUS DISEASES | COMBINATION THERAPY | CO-FORMULATED ELVITEGRAVIR | INITIAL TREATMENT | IMMUNOLOGY | RITONAVIR-BOOSTED ATAZANAVIR | EFAVIRENZ | DOUBLE-BLIND | HIV-1 INFECTION | INTEGRASE INHIBITOR | TREATMENT-NAIVE PATIENTS | HIV - enzymology | HIV Infections - drug therapy | Anti-Retroviral Agents - therapeutic use | HIV Reverse Transcriptase - antagonists & inhibitors | Humans | HIV Integrase Inhibitors - therapeutic use | Index Medicus | AIDS/HIV
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Highly Active Antiretroviral Therapy and Sexual Risk Behavior: A Meta-analytic Review
by Crepaz, Nicole and Hart, Trevor A and Marks, Gary
JAMA, ISSN 0098-7484, 07/2004, Volume 292, Issue 2, pp. 224 - 236
CONTEXT Evidence suggests that since highly active antiretroviral therapy (HAART) became available, the prevalence of unprotected sex and the incidence of... 
VIRAL LOAD | CONDOM USE | MEDICINE, GENERAL & INTERNAL | HIV-POSITIVE GAY | HETEROSEXUAL TRANSMISSION | TRANSMITTED DISEASES | VIROLOGICAL FAILURE | SAN-FRANCISCO | HOMOSEXUAL-MEN | COMBINATION THERAPIES | PROTEASE INHIBITORS | Antiretroviral Therapy, Highly Active | HIV Infections - prevention & control | Humans | Risk-Taking | Sexual Behavior - statistics & numerical data | HIV Infections - drug therapy | Health Knowledge, Attitudes, Practice | Viral Load | Drug therapy | Human immunodeficiency virus--HIV | Sexual behavior
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights